Gilteritinib vs salvage chemotherapy in FLT3-mutated acute myeloid leukemia: number needed to treat for clinical outcomes per a secondary analysis of the ADMIRAL trial
Leukemia & Lymphoma, 2022
Authors
Zeidan AM, Qi CZ, Yang H, Garnham A, Shah MV, Pandya BJ